Strongyloides stercoralis: A Rare Cause of Obstructive Duodenal Stenosis

Background: Strongyloidiasis is a rare helminthic infection in Europe, and it may cause duodenal obstruction. Methods: We report a patient who was admitted to our Medical Department with nausea and repeated vomiting since 10 years until food intake became impossible. Subsequent investigations revealed a duodenal obstruction at the upper third of the duodenum, as well as enterocolitis of the terminal ileum with eosinophils dispersed throughout the mucosa. Since food intake was still not possible after treatment with a course of i.v. PPI and prokinetic applications, we decided to perform a resection of the upper duodenum with Y-Roux reconstruction. Results: The histopathological examination of the resected specimen revealed strongyloidiasis. Conclusion: Parasite infections such as strongyloidiasis represent a rare differential diagnosis of duodenal obstruction especially if patients originate from endemic regions.

[1]  S. Boudina,et al.  Clinical manifestations of , 2009 .

[2]  D. Chi,et al.  Intestinal strongyloidiasis and hyperinfection syndrome , 2006, Clinical and molecular allergy : CMA.

[3]  H. Reinecker,et al.  Dendritic cells in the recognition of intestinal microbiota , 2006, Cellular microbiology.

[4]  W. Harrington,et al.  Intestinal strongyloidiasis: recognition, management, and determinants of outcome. , 2005, Journal of clinical gastroenterology.

[5]  K. Kain,et al.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management , 2004, Canadian Medical Association Journal.

[6]  T. Nutman,et al.  Strongyloides stercoralis in the Immunocompromised Population , 2004, Clinical Microbiology Reviews.

[7]  E. Welch,et al.  Strongyloidiasis , 2003, BMJ.

[8]  Myeong-Jin Kim,et al.  Differential diagnosis of periampullary carcinomas at MR imaging. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  H. Höfler,et al.  Gastrointestinal mesenchymal tumors – immunophenotypic classification and survival analysis , 2002, Virchows Archiv.

[10]  R. Mayer,et al.  Medical progress : Carcinoid tumors , 1999 .

[11]  P. Pitisuttithum,et al.  A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. , 1995, The Southeast Asian journal of tropical medicine and public health.

[12]  P. Gann,et al.  A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. , 1994, The Journal of infectious diseases.

[13]  R. Stone Harrison's Principles of Internal Medicine , 1991 .

[14]  J. H. Cross Strongyloidiasis: A major roundworm infection of man , 1990 .

[15]  R. Genta,et al.  Cutaneous manifestations of strongyloidiasis. , 1988, Archives of dermatology.

[16]  P. Walzer,et al.  Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. , 1981, Gastroenterology.

[17]  J. Smith,et al.  Larva currens. Cutaneous strongyloidiasis. , 1976 .

[18]  M. Liepman Disseminated Strongyloides stercoralis. A complication of immunosuppression. , 1975, JAMA.

[19]  A. Bornstein,et al.  Carcinoid Tumors , 2006 .